CAV1 and nonpapillary renal cell carcinoma: In conclusion, celastrol effectively attenuated lipid accumulation through inhibiting the interaction of CAV-1 and LOX-1, and then blocked Wnt/β-catenin signaling pathway to impair stem-like properties, thereby suppressed tumor growth of ccRCC (Figure 8).